08 September 2021 | NewsCOVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021Read the full article
NCIRS has internationally recognised expertise in evaluating new vaccines for potential use in Australia. Our expert staff are keeping a close watch on vaccine development efforts being made nationally and globally. Visit our COVID-19 vaccine development landscape page for information on vaccines currently in various stages of clinical trials in Australia and globally. We will be assessing the immunogenicity, efficacy and safety of COVID-19 vaccines when they become available. Read also the Rapid Research Information Forum (RRIF) report of the most promising vaccines for COVID-19, peer-reviewed by NCIRS Director Professor Kristine Macartney.
Visit our COVID-19 vaccine development landscape page
Visit our COVID-19 vaccines: Frequently asked questions page
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS